An enchondroma is a benign cartilage tumor that grows inside bone. It forms when cartilage cells from the growth plate fail to develop normally during childhood, persisting as small nests of cartilage within the bone’s interior instead of converting to bone tissue as they should. Most enchondromas are discovered by accident on an X-ray or MRI taken for an unrelated reason, and the vast majority never cause symptoms or require treatment.
How Enchondromas Form
During childhood, your bones grow longer through areas called growth plates, where cartilage cells multiply and gradually transform into bone. In enchondroma formation, some of these cartilage cells proliferate but never complete that transformation. Instead, they remain as cartilage inside the bone’s marrow cavity, sometimes for decades.
Researchers have traced this process to mutations in genes called IDH1 and IDH2. These mutations cause the affected cells to produce an abnormal molecule that interferes with how DNA is read and regulated. The result: cartilage cells keep growing in places they shouldn’t, and the surrounding stem cells can’t convert them into normal bone. The tumor typically starts near the center of the bone shaft and may slowly expand outward toward the outer shell (cortex) over time.
Where They Occur
Enchondromas develop in any bone that originally formed through a cartilage template, which includes most of the skeleton. They appear most frequently in the small bones of the hands and feet, where they account for a large share of all bone tumors. When an enchondroma is found in a finger bone, it is almost always benign. They also occur in the long bones of the arms and legs, particularly the femur (thigh bone) and humerus (upper arm).
Most enchondromas are solitary, meaning a person has just one. When three or more enchondromas appear in a single individual, the condition falls under a different diagnosis (described below).
Symptoms and How They’re Found
Solitary enchondromas rarely cause pain. Many people live their entire lives without knowing they have one. The tumor is typically discovered incidentally when imaging is done for a sports injury, joint pain, or another condition entirely. In the hands, an enchondroma sometimes weakens the bone enough to cause a pathological fracture, a break that happens with minimal force. That fracture, not the tumor itself, is usually what brings the person to a doctor.
When an enchondroma does cause discomfort in a long bone, that pain warrants closer attention because it can signal changes in the tumor’s behavior.
Imaging and Diagnosis
On a standard X-ray, an enchondroma appears as a well-defined area inside the bone, often with a speckled or “stippled” pattern of calcification. The bone’s outer shell stays intact, there is no reaction from the surrounding tissue, and the tumor margins are smooth and contained. These features are usually enough for a confident diagnosis, especially in the hands.
MRI or CT may be used when the X-ray findings are less clear, particularly for tumors in larger bones like the femur. These scans can reveal details that help distinguish a harmless enchondroma from something more concerning: how deeply the tumor has eroded the inner surface of the bone (called endosteal scalloping), whether there is any soft tissue involvement, and whether the outer bone shell has been disrupted.
Telling It Apart From Chondrosarcoma
The most important diagnostic question with any cartilage tumor is whether it is benign or malignant. Low-grade chondrosarcoma, a slow-growing bone cancer, can look similar to an enchondroma on imaging. Several features help separate the two:
- Size: Enchondromas are generally smaller than 5 cm. Chondrosarcomas tend to be larger.
- Pain: Enchondromas seldom hurt. A cartilage tumor causing deep, inflammatory pain raises suspicion.
- Location: A cartilage tumor in the pelvis, spine, or other central bones is treated as a potential chondrosarcoma until proven otherwise. In the finger bones, it is almost certainly benign.
- Endosteal scalloping: Erosion of the inner bone surface involving more than two-thirds of the cortical thickness strongly suggests malignancy.
- Soft tissue mass or cortical destruction: Either finding points away from a simple enchondroma.
- Change over time: An enchondroma stays stable on repeat imaging. Growth, disappearance of calcifications, or new bone reactions suggest transformation.
When imaging alone cannot settle the question, a biopsy may be performed. Under the microscope, enchondromas have a characteristic pattern: they sit in distinct nodules surrounded by a rim of normal bone and do not invade the bone marrow or the channels that carry blood vessels through bone.
Risk of Becoming Cancer
For a solitary enchondroma, the risk of malignant transformation is low. Tumors in the 3 to 7 cm range carry roughly a 2% to 3% chance of converting to chondrosarcoma. That risk climbs to about 5% for larger tumors between 8 and 15 cm. Small enchondromas in the hands carry an even lower risk, close to negligible.
The risk picture changes significantly for people with multiple enchondromas. In Ollier disease and Maffucci syndrome (covered below), the lifetime risk of developing at least one chondrosarcoma is substantially higher, making regular monitoring essential.
Monitoring Stable Enchondromas
Most solitary enchondromas that are clearly benign on imaging do not require ongoing surveillance. Some experts suggest that a single baseline X-ray is reasonable for larger lesions, providing a reference point if new symptoms ever develop. Routine repeat imaging of small, clearly benign enchondromas, particularly those found incidentally around the knee, adds cost without meaningful benefit.
For tumors in long bones that have features sitting on the borderline between benign and suspicious, periodic imaging may be recommended. The goal is to watch for growth, new endosteal scalloping, cortical erosion, or changes in the calcification pattern. Any of those changes can prompt a biopsy or surgical referral.
When Surgery Is Needed
Surgery is not necessary for most enchondromas. It becomes appropriate in specific situations: when the tumor has caused a pathological fracture, when it is large enough to weaken the bone structurally, when imaging features are ambiguous and cancer cannot be confidently ruled out, or when the tumor is causing persistent symptoms.
The standard procedure is curettage, in which the surgeon scrapes the tumor out of the bone cavity. Depending on the size and location, the resulting void may be filled with bone graft material, and the bone may be stabilized with pins or a plate. In hand enchondromas, this is typically a straightforward outpatient procedure.
Recovery After Surgery
For hand enchondromas, the finger or hand is typically immobilized in a splint for about two weeks, after which physical therapy begins. If pins were placed, they are usually removed around six weeks. Most patients achieve full range of motion and return to normal activities within 10 to 12 weeks, with X-rays at that point confirming that the bone graft has consolidated and the cavity has filled in. Recurrence after curettage is uncommon.
Early movement after stable fixation is important for preventing stiffness, especially in the fingers. Grip and pinch strength typically return to normal once rehabilitation is complete.
Ollier Disease and Maffucci Syndrome
When a person develops three or more enchondromas, the condition may be classified as Ollier disease or Maffucci syndrome, depending on whether vascular abnormalities are also present. Both are rare and caused by the same type of IDH1 and IDH2 mutations found in solitary enchondromas, though in these conditions the mutations affect a broader population of cells during early development.
Ollier disease features multiple enchondromas that typically appear in the first decade of life. The tumors tend to cluster on one side of the body and favor the arms and legs. Complications include bone shortening, limb-length differences, joint deformity, scoliosis, and pathological fractures. In the literature, roughly 58% of patients have enchondromas confined to one side of the body, though bilateral involvement with asymmetric distribution is also common.
Maffucci syndrome includes all the features of Ollier disease plus benign vascular overgrowths, most often in the hands, arms, and legs. About 13% of cases are noticeable in the first year of life. The vascular lesions themselves become malignant in approximately 8.5% of cases and can also involve internal structures like the membranes surrounding the brain and the lining of the mouth. Both conditions carry a significantly elevated lifetime risk of chondrosarcoma compared to solitary enchondromas, making long-term clinical and imaging follow-up a routine part of care.